A randomised study to evaluate the potential added value of shared meditation involving people with cancer, health professionals and third persons compared to meditation conducted with patients only: design of the Implic-2 protocol.
BMC cancer September 4, 2024 Virginie Prevost, Titi Tran, Alexandra Leconte et al. 2 citations
A two-arm randomised trial will test whether adding shared meditation sessions that include cancer patients, health professionals, and third parties improves well-being more than meditation limited to patients alone. The study plans to enroll 96 participants: 64 patients, 16 health professionals, and 16 third persons. Patients in the experimental arm will meditate in mixed groups, while those in the control arm will meditate in patient-only groups. Outcomes include quality of life, perceived stress, self-efficacy, mindfulness, self-compassion, and carer burnout. A qualitative focus-group component will help optimize future implementation.